Although miR‐223 enhanced IL‐6 expression in CSCC cells to some extent, the difference in the IL‐6 levels exhibited in the tumor tissues (TCGA cohort) was considered to be contributed by other cells (Fig. 7C). The gene discussed is IL6; the disease is neoplasm.